Clinical Trial Update: Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL) [NA]

View source ↗

Summary

Open-label clinical trial evaluating transcranial photobiomodulation to reduce autism symptoms in children has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: JelikaLite LLC | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED | Results posted: 2024-06-06